已核实 DOI PubMed 相关产品: 184

Enantioseparation of flurbiprofen enantiomers using chiral ionic liquids by liquid-liquid extraction

Journal 2019 · IF 1.927 · 31(6): 457-467 · 发表于 2019 年 5 月 7 日
作者: Xing Cui,Qi Ding,Ruo-Ni Shan,Chao-Hong He,Ke-Jun Wu
阅读全文 在 PubMed 查看

摘要

Flurbiprofen is a kind of nonsteroidal anti-inflammatory drug, which has been widely used in clinic for treatment of rheumatoid arthritis and osteoarthritis. It has been reported that S-flurbiprofen shows good performance on clinic anti-inflammatory treatment, while R-enantiomer almost has no pharmacological activities. It has important practical values to obtain optically pure S-flurbiprofen. In this work, chiral ionic liquids, which have good structural designability and chiral recognize ability, were selected as the extraction selector by the assistance of quantum chemistry calculations. The distribution behaviors of flurbiprofen enantiomers were investigated in the extraction system, which was composed of organic solvent and aqueous phase containing chiral ionic liquid. The results show that maximum enantioselectivity up to 1.20 was attained at pH 2.0, 25°C using 1,2-dichloroethane as organic solvent, 1-butyl-3-methylimidazole L-tryptophan ([Bmim][L-trp]) as chiral selector. The racemic flurbiprofen initial concentration was 0.2 mmol L −1 , and [Bmim][L-trp] concentration was 0.02 mol L −1 . Furthermore, the recycle of chiral ionic liquids has been achieved by reverse extraction process of the aqueous phase with chiral selector, which is significant for industrial application of chiral ionic liquids and scale-up of the extraction process.

本研究中使用的阿拉丁产品

184 款产品在本文中被引用